Preprocedural SII Combined with High-Sensitivity C-Reactive Protein Predicts the Risk of Contrast-Induced Acute Kidney Injury in STEMI Patients Undergoing Percutaneous Coronary Intervention

References

• Mettler FA Jr, Mahesh M, Bhargavan-Chatfield M, et al. Patient exposure from radiologic and nuclear medicine procedures in the United States: procedure volume and effective dose for the period 2006–2016. Radiology. 2020;295(2):418–427. doi:10.1148/radiol.2020192256
   PubMed Web of Science ®Google Scholar
• Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart. 2016;102(8):638–648. doi:10.1136/heartjnl-2014-306962
   PubMed Web of Science ®Google Scholar
• Abe D, Sato A, Hoshi T, et al. Clinical predictors of contrast-induced acute kidney injury in patients undergoing emergency versus elective percutaneous coronary intervention. Circ J. 2014;78(1):85–91. doi:10.1253/circj.cj-13-0574
   PubMed Web of Science ®Google Scholar
• Marenzi G, Cosentino N, Bartorelli AL. Acute kidney injury in patients with acute coronary syndromes. Heart. 2015;101(22):1778–1785. doi:10.1136/heartjnl-2015-307773
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ, Bozbeyoglu E, Yıldırımtürk Ö, Tekkeşin Aİ, Pehlivanoğlu S. Effect of acute kidney injury on long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock who underwent primary percutaneous coronary intervention in a high-volume tertiary center. Turk Kardiyol Dern Ars. 2020;48(1):1–9. doi:10.5543/tkda.2019.84401
   PubMed Web of Science ®Google Scholar
• Hossain MA, Costanzo E, Cosentino J, et al. Contrast-induced nephropathy: pathophysiology, risk factors, and prevention. Saudi J Kidney Dis Transpl. 2018;29(1):1–9. doi:10.4103/1319-2442.225199
   PubMed Web of Science ®Google Scholar
• Bağcı A, Aksoy F, Baş HA. Systemic immune-inflammation index may predict the development of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Angiology. 2022;73(3):218–224. doi:10.1177/00033197211030053
   PubMed Web of Science ®Google Scholar
• Ortolani P, Marzocchi A, Marrozzini C, et al. Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. Eur Heart J. 2008;29(10):1241–1249. doi:10.1093/eurheartj/ehm338
   PubMed Web of Science ®Google Scholar
• Liu Y, Tan N, Zhou YL, et al. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention. J Nephrol. 2012;25(3):332–340. doi:10.5301/jn.5000007
   PubMed Web of Science ®Google Scholar
• Ozbek E, Besiroglu H, Ozer K, Horsanali MO, Gorgel SN. Systemic immune inflammation index is a promising non-invasive marker for the prognosis of the patients with localized renal cell carcinoma. Int Urol Nephrol. 2020;52(8):1455–1463. doi:10.1007/s11255-020-02440-y
   PubMed Web of Science ®Google Scholar
• Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med. 2019;380(22):2146–2155. doi:10.1056/NEJMra1805256
   PubMed Web of Science ®Google Scholar
• Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. Eur Radiol. 2011;21(12):2527–2541. doi:10.1007/s00330-011-2225-0
   PubMed Web of Science ®Google Scholar
• Sato A, Aonuma K, Watanabe M, et al. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: from the CINC-J study. Int J Cardiol. 2017;227:424–429. doi:10.1016/j.ijcard.2016.11.019
   PubMed Web of Science ®Google Scholar
• Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv. 2005;64(4):442–448. doi:10.1002/ccd.20316
   PubMed Web of Science ®Google Scholar
• Akcay A, Nguyen Q, Edelstein CL. Mediators of inflammation in acute kidney injury. Mediators Inflamm. 2009;2009:137072. doi:10.1155/2009/137072
   PubMed Web of Science ®Google Scholar
• Yun KH. Contrast-induced acute kidney injury and inflammation. Korean Circ J. 2018;48(1):84–85. doi:10.4070/kcj.2017.0357
   PubMed Web of Science ®Google Scholar
• Nagareddy P, Smyth SS. Inflammation and thrombosis in cardiovascular disease. Curr Opin Hematol. 2013;20(5):457–463. doi:10.1097/MOH.0b013e328364219d
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-0442
   PubMed Web of Science ®Google Scholar
• Jin Z, Wu Q, Chen S, et al. The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals. J Inflamm Res. 2021;14:131–140. doi:10.2147/JIR.S283835
   PubMed Web of Science ®Google Scholar
• Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
   PubMed Web of Science ®Google Scholar
• Huang J, Zhang Q, Wang R, et al. Systemic immune-inflammatory index predicts clinical outcomes for elderly patients with acute myocardial infarction receiving percutaneous coronary intervention. Med Sci Monit. 2019;25:9690–9701. doi:10.12659/MSM.919802
   PubMed Web of Science ®Google Scholar
• Fest J, Ruiter R, Ikram MA, Voortman T, van Eijck C, Stricker BH. Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study. Sci Rep. 2018;8(1):10566. doi:10.1038/s41598-018-28646-w
   PubMed Web of Science ®Google Scholar
• Peng Y, Huang W, Shi Z, Chen Y, Ma J. Positive association between systemic immune-inflammatory index and mortality of cardiogenic shock. Clin Chim Acta. 2020;511:97–103. doi:10.1016/j.cca.2020.09.022
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ, Çınar T, Çinier G, et al. Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction. Pacing Clin Electrophysiol. 2022;45(2):188–195. doi:10.1111/pace.14436
   PubMed Web of Science ®Google Scholar
• Bağcı A, Aksoy F, Baş HA. Systemic immune-inflammation index may predict the development of contrast-induced nephropathy in patients with st-segment elevation myocardial infarction. Angiology. 2021;33197211030053. doi:10.1177/00033197211030053
   Web of Science ®Google Scholar
• Jansen MP, Emal D, Teske GJ, Dessing MC, Florquin S, Roelofs JJ. Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps. Kidney Int. 2017;91(2):352–364. doi:10.1016/j.kint.2016.08.006
   PubMed Web of Science ®Google Scholar
• Wang CH, Zhang SY, Fang Q, et al. Renal dysfunction and hsCRP predict long-term outcomes of percutaneous coronary intervention in acute myocardial infarction. Am J Med Sci. 2015;349(5):413–420. doi:10.1097/MAJ.0000000000000430
   PubMed Web of Science ®Google Scholar
• Chen R, Liu C, Zhou P, et al. Both low and high postprocedural hsCRP associate with increased risk of death in acute coronary syndrome patients treated by percutaneous coronary intervention. Mediators Inflamm. 2020;2020:9343475. doi:10.1155/2020/9343475
   PubMed Web of Science ®Google Scholar
• Jian-Wei Z, Yu-Jie Z, Shu-Jun C, Qing Y, Shi-Wei Y, Bin N. Impact of preprocedural high-sensitivity C-reactive protein on contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention. Angiology. 2014;65(5):402–407. doi:10.1177/0003319713482177
   PubMed Web of Science ®Google Scholar
• Çinier G, Hayıroğlu Mİ, Kolak Z, et al. The value of C-reactive protein-to-albumin ratio in predicting long-term mortality among HFrEF patients with implantable cardiac defibrillators. Eur J Clin Invest. 2021;51(8):e13550. doi:10.1111/eci.13550
   PubMed Web of Science ®Google Scholar
• Ribeiro DR, Ramos AM, Vieira PL, et al. High-sensitivity C-reactive protein as a predictor of cardiovascular events after ST-elevation myocardial infarction. Arq Bras Cardiol. 2014;103(1):69–75. doi:10.5935/abc.20140086
   PubMed Web of Science ®Google Scholar
• Xinwei J, Xianghua F, Jing Z, et al. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol. 2009;104(4):519–524. doi:10.1016/j.amjcard.2009.04.014
   PubMed Web of Science ®Google Scholar
• Peruzzi M, De Luca L, Thomsen HS, et al. A network meta-analysis on randomized trials focusing on the preventive effect of statins on contrast-induced nephropathy. Biomed Res Int. 2014;2014:213239. doi:10.1155/2014/213239
   PubMed Web of Science ®Google Scholar